Skip to main content
Premium Trial:

Request an Annual Quote

Biofortuna to Provide HLA Kits for Lab901's PCR-Based Diagnostic Platform

Premium

Lab901 and Biofortuna said this week that they will collaborate on the development of an automated PCR-based diagnostic system for the rapid detection of celiac disease and other diseases related to human leukocyte antigen status.

Lab901, based in Edinburgh, UK, said that it will optimize its ScreenTape PCR diagnostics platform for use with Liverpool, UK-based Biofortuna’s multiplex PCR diagnostics kits for the detection of celiac disease and other HLA-related diseases such as reactive arthritis, diabetes, and drug hypersensitivity.

The ScreenTape PCR diagnostics platform includes an instrument, consumables, and analysis software that automatically interprets results.

Biofortuna said that its genotyping tests combine multiplexing and a "novel dried format that only requires addition of sample DNA prior to PCR." Its celiac disease test identifies six different polymorphisms associated with susceptibility to the disease.

Financial terms of the agreement were not disclosed.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.